Literature DB >> 315964

Biotypes of Haemophilus encountered in clinical laboratories.

T R Oberhofer, A E Back.   

Abstract

The biochemical characteristics of 464 strains of Haemophilus influenzae and 83 strains of Haemophilus parainfluenzae isolated over an 18-month period are described. Of 22 characteristics obtained, only 6 were necessary to biochemically identify and biotype the isolates. The key substrates or tests were urease, ornithine, indole, o-nitrophenyl-beta-D-galactopyranoside, sucrose, and xylose. Five biotypes of H. influenzae and four of H. parainfluenzae were commonly recognized. Some strains were encountered which could not be accommodated in the recognized taxa but which constituted separate biotypes of the two species, H. influenzae biotype I was recovered principally from blood, cerebrospinal fluid, and upper respiratory secretion, and biotypes II and III were recovered from eye and sputum cultures. Biotype I was recovered primarily from children less than 1 year of age, whereas biotypes II and III were from persons 1 to 5 years old and from those over 20 years of age. Multiple isolates recovered from the same patient were almost always of the same biotype. Strains of H. parainfluenzae were isolated primarily from sputum, with others being isolated from body sources such as dental abscesses, gastric aspirates, and peritoneal fluid. An inverse relationship was noticed between hemolysis and mannose fermentation among H. parainfluenzae biotype III strains, whereas the relationship was absent among the other biotypes.

Entities:  

Mesh:

Year:  1979        PMID: 315964      PMCID: PMC273122          DOI: 10.1128/jcm.10.2.168-174.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  HAEMOPHILUS INFLUENZAE TYPE-C BRONCHOPNEUMONIA.

Authors:  M B LOWE
Journal:  J Pathol Bacteriol       Date:  1964-07

2.  Studies on Haemophilus influenzae; biochemical activities.

Authors:  G TUNEVALL
Journal:  Acta Pathol Microbiol Scand       Date:  1951

3.  Identification of the Koch-Weeks bacillus (Hemophilus aegyptius).

Authors:  M PITTMAN; D J DAVIS
Journal:  J Bacteriol       Date:  1950-03       Impact factor: 3.490

4.  Bacteremia associated with Haemophilus influenzae type e biotype 4.

Authors:  T H Cawthern; R V Marraro; F K McCleskey
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

5.  Pneumonia due to Haemophilus influenzae (H. aegyptius) biotype 3.

Authors:  R V Marraro; F K McCleskey; J L Mitchell
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

6.  Biochemical characteristics of Haemophilus influenzae in relationship to source of isolation and antibiotic resistance.

Authors:  W L Albritton; S Penner; L Slaney; J Brunton
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

7.  Use of the Minitek system for biotyping Haemophilus species.

Authors:  A E Back; T R Oberhofer
Journal:  J Clin Microbiol       Date:  1978-03       Impact factor: 5.948

8.  Haemophilus influenzae pneumonia in adults.

Authors:  E D Everett; A E Rham; R Adaniya; D L Stevens; T R McNitt
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272

9.  Reevaluation of neonatal Hemophilus influenzae infections.

Authors:  L K Pickering; F A Simon
Journal:  South Med J       Date:  1977-02       Impact factor: 0.954

10.  Hemophilus influenzae pneumonia in adults.

Authors:  R J Wallace; D M Musher; R R Martin
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

View more
  37 in total

1.  Neonatal, urogenital isolates of biotype 4 nontypeable Haemophilus influenzae express a variant P6 outer membrane protein molecule.

Authors:  T F Murphy; C Kirkham; D J Sikkema
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzae.

Authors:  Erik L Munson; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

3.  Variation in metabolic enzyme activity of persistent Haemophilus influenzae in respiratory tracts of patients with cystic fibrosis.

Authors:  L V Möller; H Grasselier; J Dankert; L van Alphen
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

4.  Evaluation of two rapid methods for identifying and biotyping Haemophilus influenzae.

Authors:  P G Murphy; I Craig; A C Lafong; E T Smyth
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

5.  Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV.

Authors:  R Quentin; J M Musser; M Mellouet; P Y Sizaret; R K Selander; A Goudeau
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986.

Authors:  M Powell; C Koutsia-Carouzou; D Voutsinas; A Seymour; J D Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

7.  Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test.

Authors:  D F Welch; P A Ahlin; J M Matsen
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

8.  Distribution of Haemophilus influenzae and Haemophilus parainfluenzae biotypes isolated from the human genitourinary tract.

Authors:  E B Drouet; G A Denoyel; M M Boude; G Boussant; H P de Montclos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

9.  Clinical evaluation of the Vitek Neisseria-Haemophilus Identification card.

Authors:  W M Janda; P J Malloy; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.

Authors:  D M Musher; A Goree; R E Baughn; H H Birdsall
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.